Healthcare
Live Price
Offline$0.2502
-15.19% today
Window Change
-36.77%
Window
Aug 29, 2025 → Jun 15, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 196 bars · Aug 29, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
YD Bio Limited Warrants (YDESW) is a Healthcare stock with a market cap of $350.00M and listed on NASDAQ. The stock last traded around $0.25 and down 36.8% across the available one-year price window (Aug 29, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +45.8%, EPS growth of -280100.0%, a dividend yield of 0.0%. What stands out right now is revenue +45.8%, EPS -280100.0%, free cash flow -8386.3% with operating margin 0.0% and ROIC 13.6%. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YDESW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YDESW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YDESW Max Drawdown
-89.07%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YDESW and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for YDESW
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.